Transarterial chemoembolization in patients with hepatocellular carcinoma: predictors of survival.

Summit Sawhney,Aldo J. Montano-Loza,Peter Šalát,Mairin McCarthy,Norman M. Kneteman,Judith Meza-Junco,Richard J. Owen

Transarterial chemoembolization in patients with hepatocellular carcinoma: predictors of survival.

2011

Summit Sawhney
Aldo J. Montano-Loza
Peter Šalát
Mairin McCarthy
Norman M. Kneteman
Judith Meza-Junco
Richard J. Owen

BACKGROUND: Transarterial chemoembolization (TACE) is the mainstay of management for patients with hepatocellular carcinoma who are not suitable for curative treatments.

Keywords:

Diabetes mellitus
Severity of illness
General surgery
Hepatocellular carcinoma
Retrospective cohort study
Medicine
Survival rate
Proportional hazards model
Oncology
Young adult
in patient
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations